News & Events
Insight Genetics announced that it has been awarded a $244,479 grant to advance the development of novel molecular diagnostic tests for cancer. The grant was awarded by the Internal Revenue Service and the U.S. Department of Health and Human Services as part of the Qualifying Therapeutic Discovery Project Program (QTDP), which was established under the Patient Protection and Affordable Care Act of 2010.
Insight Genetics today announced that it has been awarded a $200,000 Phase I Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI) to develop a new test for lung cancer patients. The contract was awarded as part of a solicitation titled, “Companion Diagnostics: Predictive and Prognostic Tests Enabling Personalized Medicine in Cancer Therapy.”